TrialEsophagus : official journal of the Japan Esophageal Society2024

A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma.

Tomoki Makino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.